
Natera (NTRA) Stock Forecast & Price Target
Natera (NTRA) Analyst Ratings
Bulls say
Natera is well positioned in the growing MRD market with a dominant market share and successful product offering, Signatera, which has experienced significant growth. With a diverse portfolio expanding into new markets, strong financials and a positive outlook for future growth, it is no surprise that the company has received an Outperform rating and a $275 price target. However, potential risks and challenges, such as competition and reliance on senior management, should be carefully monitored.
Bears say
Natera is a leader in diagnostic and research services, but faces challenges in maintaining its momentum and profit margins due to potential limitations on its unique technologies, inconsistent realization of planned catalysts and increasingly competitive and intense markets they operate in, also posing moderate risks to profitable operation.
This aggregate rating is based on analysts' research of Natera and is not a guaranteed prediction by Public.com or investment advice.
Natera (NTRA) Analyst Forecast & Price Prediction
Start investing in Natera (NTRA)
Order type
Buy in
Order amount
Est. shares
0 shares